Yahoo
NSE - Free Realtime Quote INR

Strides Pharma Science Limited (STAR.NS)

1,005.80 -30.10 (-2.91%)
As of 2:42:56 PM GMT+5:30. Market Open.
View in AlphaSpace Currency in INR All numbers in thousands
Financial statements have been upgraded
A new layout with more detail in every statement.
TTM
3/31/2026
3/31/2025
3/31/2024
3/31/2023
Total Revenue
52,132,570 46,279,660 43,916,820 37,300,230 36,076,690
Cost of Revenue
-21,238,020 -21,673,590 -21,339,110 -18,835,520 -17,458,500
Gross Profit
30,894,550 24,606,070 22,577,710 18,464,710 18,618,190
Selling, General and Administrative Expenses
-9,579,180 -14,453,150 -13,021,880 -10,698,680 -11,577,590
Operation and Maintenance Expenses
-1,829,630 -1,829,630 -1,485,070 -1,618,160 -1,311,390
Depreciation, Amortization and Depletion
-2,174,860 -2,024,010 -1,922,600 -2,206,830 -2,432,520
Taxes Other Than Income Taxes
-613,660 -613,660 -574,750 -613,780 -522,310
Provision Expense/Write-Back
63,180 63,180 -10,850 -147,340 -335,770
Other Income/Expense, Operating
-11,751,970 421,350 233,470 30,910 -1,009,800
Operating Income/Expenses
-23,506,010 -18,435,920 -16,781,680 -15,253,880 -17,189,380
Total Operating Profit/Loss
7,388,540 6,170,150 5,796,030 3,210,830 1,428,810
Total Net Finance Income/Expense
-1,720,600 -1,513,450 -2,034,820 -2,505,820 -1,866,350
Net Investment Income
10,320 1,903,210 78,130 -435,390 -2,403,740
Rental Income
12,690 12,690 21,010 17,930 19,000
Irregular Income/Expenses
517,890 67,130 963,550 -1,565,590 -129,250
Other Income/Expense, Non-Operating
1,239,630 47,130 45,310 59,710 89,530
Non-Operating Income/Expenses, Total
47,240 516,710 -926,820 -4,429,160 -4,290,810
Pretax Income
7,435,780 6,686,860 4,869,210 -1,147,920 -2,862,000
Provision for Income Tax
-1,065,640 -941,660 -775,160 -291,120 553,010
Net Income from Continuing Operations
6,370,140 5,745,200 4,094,050 -1,439,040 -2,308,990
Discontinued Operations
0 0 31,881,070 495,920 185,690
Net Income after Extraordinary Items and Discontinued Operations
6,370,140 5,745,200 35,975,120 -943,120 -2,123,300
Non-Controlling/Minority Interests
-202,130 -183,270 -40,570 237,000 96,950
Net Income after Non-Controlling/Minority Interests
6,168,010 5,561,930 35,934,550 -706,120 -2,026,350
Net Income Available to Common Stockholders
6,168,010 5,561,930 35,934,550 -706,120 -2,026,350
Diluted Net Income Available to Common Stockholders
6,168,010 5,561,930 35,934,550 -706,120 -2,026,350
Common Dividend per Share
5.00 5.00 4.00 2.50 1.50
Basic EPS
66.92 60.34 390.55 -7.76 -22.49
Diluted EPS
66.91 60.34 390.50 -7.76 -22.49
Basic Weighted Average Shares Outstanding
92,161.57 92,169.45 92,011.24 91,001.82 90,080.78
3/31/2023 - 6/26/2002

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: